A citation-based method for searching scientific literature

Stefan D Anker, Javed Butler, Gerasimos Filippatos, João P Ferreira, Edimar Bocchi, Michael Böhm, Hans-Peter Brunner-La Rocca, Dong-Ju Choi, Vijay Chopra, Eduardo Chuquiure-Valenzuela, Nadia Giannetti, Juan Esteban Gomez-Mesa, Stefan Janssens, James L Januzzi, Jose R Gonzalez-Juanatey, Bela Merkely, Stephen J Nicholls, Sergio V Perrone, Ileana L Piña, Piotr Ponikowski, Michele Senni, David Sim, Jindrich Spinar, Iain Squire, Stefano Taddei, Hiroyuki Tsutsui, Subodh Verma, Dragos Vinereanu, Jian Zhang, Peter Carson, Carolyn Su Ping Lam, Nikolaus Marx, Cordula Zeller, Naveed Sattar, Waheed Jamal, Sven Schnaidt, Janet M Schnee, Martina Brueckmann, Stuart J Pocock, Faiez Zannad, Milton Packer. N Engl J Med 2021
Times Cited: 378



Darren K McGuire, Weichung J Shih, Francesco Cosentino, Bernard Charbonnel, David Z I Cherney, Samuel Dagogo-Jack, Richard Pratley, Michelle Greenberg, Shuai Wang, Susan Huyck, Ira Gantz, Steven G Terra, Urszula Masiukiewicz, Christopher P Cannon. JAMA Cardiol 2021
Times Cited: 189




List of shared articles



Times cited

Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial.
Gerasimos Filippatos, Stefan D Anker, Rajiv Agarwal, Luis M Ruilope, Peter Rossing, George L Bakris, Christoph Tasto, Amer Joseph, Peter Kolkhof, Andrea Lage,[...]. Circulation 2022
3

SGLT-2 Inhibitors on Top of Current Pharmacological Treatments for Heart Failure: A Comparative Review on Outcomes and Cost Effectiveness.
Ilaria Cavallari, Ernesto Maddaloni, Annunziata Nusca, Dario Tuccinardi, Raffaella Buzzetti, Paolo Pozzilli, Francesco Grigioni. Am J Cardiovasc Drugs 2022
0

Dysglycemia and incident heart failure among blacks: The jackson heart study.
Justin B Echouffo-Tcheugui, Stanford E Mwasongwe, Solomon K Musani, Michael E Hall, Adolfo Correa, Adrian F Hernandez, Sherita H Golden, Robert J Mentz, Alain G Bertoni. Am Heart J 2022
2

Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction.
Javed Butler, Milton Packer, Gerasimos Filippatos, Joao Pedro Ferreira, Cordula Zeller, Janet Schnee, Martina Brueckmann, Stuart J Pocock, Faiez Zannad, Stefan D Anker. Eur Heart J 2022
20

Sodium-glucose cotransporter 2 inhibitors: the first universal treatment for heart failure?
Kirsty McDowell, Kieran F Docherty. Eur Heart J Qual Care Clin Outcomes 2022
0

DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases.
Yehuda Handelsman, John E Anderson, George L Bakris, Christie M Ballantyne, Joshua A Beckman, Deepak L Bhatt, Zachary T Bloomgarden, Biykem Bozkurt, Matthew J Budoff, Javed Butler,[...]. J Diabetes Complications 2022
1

The year in cardiovascular medicine 2021: diabetes and metabolic disorders.
Francesco Cosentino, Deepak L Bhatt, Nikolaus Marx, Subodh Verma. Eur Heart J 2022
2

SGLT-2 inhibitors and cardiovascular outcomes in patients with and without a history of heart failure: a systematic review and meta-analysis.
Victor Razuk, Mauro Chiarito, Davide Cao, Johny Nicolas, Carlo A Pivato, Anton Camaj, David Power, Frans Beerkens, Davis Jones, Aviv Alter,[...]. Eur Heart J Cardiovasc Pharmacother 2022
1

Sodium-glucose cotransporter 2 inhibitors in heart failure with reduced or preserved ejection fraction: a meta-analysis.
Arjun K Pandey, Nitish K Dhingra, Makoto Hibino, Vijay Gupta, Subodh Verma. ESC Heart Fail 2022
1

Glycemic Markers and Heart Failure Subtypes: The Multi-Ethnic Study of Atherosclerosis (MESA).
Justin B Echouffo-Tcheugui, Oluseye Ogunmoroti, Sherita H Golden, Alain G Bertoni, Morgana Mongraw-Chaffin, Ambarish Pandey, Chiadi E Ndumele, Erin D Michos. J Card Fail 2022
2